Fri, Apr 18, 2014, 6:07 AM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Incyte Corporation Message Board

  • tjnelis tjnelis Sep 14, 2011 11:54 AM Flag

    FDA and incy 424

    based on the time frame, the fda has until the 1st of October to contact Incyte and meet with them and an advisory committe/board....if not based on a based a past results of 2 other drugs , one by pfizer, 424 will be approved, and more than likely before DEC-3....as per the morgan stanley call today

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I think there is a chance that ruxolitinib will be approved before the PDUFA date. It may not extend patients' lives like vemurafenib and crizotinib do, but IMO there is a clear improvement in patients' quality of life. When you also consider that there are no comparable treatment options out there for MF, I think there is a strong rationale more making the drug available ASAP.

 
INCY
44.54+0.56(+1.27%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT
KeyCorp.
NYSEThu, Apr 17, 2014 4:01 PM EDT
AsiaInfo-Linkage, Inc.
NasdaqGSWed, Jan 15, 2014 4:00 PM EST